Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (Dec 2019)

Measuring longitudinal cognition: Individual tests versus composites

  • Erin M. Jonaitis,
  • Rebecca L. Koscik,
  • Lindsay R. Clark,
  • Yue Ma,
  • Tobey J. Betthauser,
  • Sara E. Berman,
  • Samantha L. Allison,
  • Kimberly D. Mueller,
  • Bruce P. Hermann,
  • Carol A. Van Hulle,
  • Bradley T. Christian,
  • Barbara B. Bendlin,
  • Kaj Blennow,
  • Henrik Zetterberg,
  • Cynthia M. Carlsson,
  • Sanjay Asthana,
  • Sterling C. Johnson

DOI
https://doi.org/10.1016/j.dadm.2018.11.006
Journal volume & issue
Vol. 11, no. 1
pp. 74 – 84

Abstract

Read online

Abstract Introduction Longitudinal cohort studies of cognitive aging must confront several sources of within‐person variability in scores. In this article, we compare several neuropsychological measures in terms of longitudinal error variance and relationships with biomarker‐assessed brain amyloidosis (Aβ). Methods Analyses used data from the Wisconsin Registry for Alzheimer's Prevention. We quantified within‐person longitudinal variability and age‐related trajectories for several global and domain‐specific composites and their constituent scores. For a subset with cerebrospinal fluid or amyloid positron emission tomography measures, we examined how Aβ modified cognitive trajectories. Results Global and theoretically derived composites exhibited lower intraindividual variability and stronger age × Aβ interactions than did empirically derived composites or raw scores from single tests. For example, the theoretical executive function outperformed other executive function scores on both metrics. Discussion These results reinforce the need for careful selection of cognitive outcomes in study design, and support the emerging consensus favoring composites over single‐test measures.

Keywords